Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
72.1M
-
Shares change
-
+2.67M
-
Total reported value, excl. options
-
$939M
-
Value change
-
+$36.2M
-
Put/Call ratio
-
0.11
-
Number of buys
-
65
-
Number of sells
-
-62
-
Price
-
$13.01
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q3 2022
169 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q3 2022.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.1M shares
of 101M outstanding shares and own 71.47% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (13.2M shares), VANGUARD GROUP INC (9.74M shares), BlackRock Inc. (7.17M shares), Point72 Asset Management, L.P. (4.78M shares), ARMISTICE CAPITAL, LLC (4.46M shares), STATE STREET CORP (4.22M shares), FIRST TRUST ADVISORS LP (3.63M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.75M shares), GEODE CAPITAL MANAGEMENT, LLC (1.61M shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (1.43M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.